These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8056999)

  • 1. Neuroendocrine responses to single doses of buspirone in obsessive-compulsive disorder.
    Norman TR; Apostolopoulos M; Burrows GD; Judd FK
    Int Clin Psychopharmacol; 1994; 9(2):89-94. PubMed ID: 8056999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone induced prolactin responses in obsessive-compulsive disorder (OCD): is OCD a 5-HT2 receptor disorder?
    Lucey JV; Butcher G; Clare AW; Dinan TG
    Int Clin Psychopharmacol; 1992; 7(1):45-9. PubMed ID: 1624756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buspirone augmentation of fluoxetine in obsessive-compulsive disorder.
    Markovitz PJ; Stagno SJ; Calabrese JR
    Am J Psychiatry; 1990 Jun; 147(6):798-800. PubMed ID: 2188516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin and cortisol responses to MK-212, a serotonin agonist, in obsessive-compulsive disorder.
    Bastani B; Nash JF; Meltzer HY
    Arch Gen Psychiatry; 1990 Sep; 47(9):833-9. PubMed ID: 2203327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of buspirone on plasma prolactin and cortisol levels in major depressed and normal subjects.
    Meltzer HY; Maes M
    Biol Psychiatry; 1994 Mar; 35(5):316-23. PubMed ID: 8011800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin syndrome from fluvoxamine and buspirone.
    Baetz M; Malcolm D
    Can J Psychiatry; 1995 Sep; 40(7):428-9. PubMed ID: 8548727
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response.
    Navinés R; Martín-Santos R; Gómez-Gil E; Martínez de Osaba MJ; Imaz ML; Gastó C
    Psychoneuroendocrinology; 2007 May; 32(4):411-6. PubMed ID: 17337123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin function in obsessive-compulsive disorder. A comparison of the effects of tryptophan and m-chlorophenylpiperazine in patients and healthy subjects.
    Charney DS; Goodman WK; Price LH; Woods SW; Rasmussen SA; Heninger GR
    Arch Gen Psychiatry; 1988 Feb; 45(2):177-85. PubMed ID: 3337615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroendocrine and behavioral responses to challenge with the indirect serotonin agonist dl-fenfluramine in adults with obsessive-compulsive disorder.
    McBride PA; DeMeo MD; Sweeney JA; Halper J; Mann JJ; Shear MK
    Biol Psychiatry; 1992 Jan; 31(1):19-34. PubMed ID: 1311964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin response to buspirone is not impaired in drug-naïve first episode patients with major depressive disorder.
    Cubała WJ; Landowski J
    J Affect Disord; 2014 Jan; 152-154():468-73. PubMed ID: 24035672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An open trial of buspirone in obsessive-compulsive disorder.
    Jenike MA; Baer L
    Am J Psychiatry; 1988 Oct; 145(10):1285-6. PubMed ID: 3048120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serotonin hypothesis of obsessive compulsive disorder.
    Barr LC; Goodman WK; Price LH
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():79-82. PubMed ID: 8201248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anterior pituitary responds normally to protirelin in obsessive-compulsive disorder: evidence to support a neuroendocrine serotonergic deficit.
    Lucey JV; Butcher G; Clare AW; Dinan TG
    Acta Psychiatr Scand; 1993 Jun; 87(6):384-8. PubMed ID: 8356888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled comparison of buspirone and clomipramine in obsessive-compulsive disorder.
    Pato MT; Pigott TA; Hill JL; Grover GN; Bernstein S; Murphy DL
    Am J Psychiatry; 1991 Jan; 148(1):127-9. PubMed ID: 1984696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment.
    Gómez-Gil E; Navinés R; Martínez De Osaba MJ; Díaz-Ricart M; Escolar G; Salamero M; Martín-Santos R; Galán A; Gastó C
    Psychoneuroendocrinology; 2010 May; 35(4):481-9. PubMed ID: 19762159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder.
    Hollander E; DeCaria C; Gully R; Nitescu A; Suckow RF; Gorman JM; Klein DF; Liebowitz MR
    Psychiatry Res; 1991 Jan; 36(1):1-17. PubMed ID: 2017519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity of 5-HT2 receptors in OCD patients. An increased prolactin response after a challenge with meta-chlorophenylpiperazine and pre-treatment with ritanserin and placebo.
    de Leeuw AS; Westenberg HG
    J Psychiatr Res; 2008 Sep; 42(11):894-901. PubMed ID: 18533183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.
    Khanna S; John JP; Reddy LP
    Psychoneuroendocrinology; 2001 Feb; 26(2):209-23. PubMed ID: 11087965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone.
    Cassidy EM; Tomkins E; Sharifi N; Dinan T; Hardiman O; O'Keane V
    Pain; 2003 Feb; 101(3):283-290. PubMed ID: 12583871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortisol and prolactin responses to d-fenfluramine in non-depressed patients with obsessive-compulsive disorder: a comparison with depressed and healthy controls.
    Lucey JV; O'Keane V; Butcher G; Clare AW; Dinan TG
    Br J Psychiatry; 1992 Oct; 161():517-21. PubMed ID: 1393339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.